Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Brain research – April 02, 2004
Source: PubMed
Summary
A fascinating discovery reveals that a plant-derived compound, ibogaine, alters brain activity in profoundly different ways depending on whether an individual is drug-naive or morphine-dependent. Researchers investigated how ibogaine impacts brain energy use, specifically glucose utilization, in rats. They found that in drug-naive animals, ibogaine increased activity in areas linked to its known hallucinogenic effects. Crucially, in morphine-dependent rats, ibogaine led to a widespread *decrease* in brain energy use, particularly in regions associated with reward and addiction. These distinct responses suggest ibogaine's potential in treating addiction may operate through mechanisms separate from its hallucinogenic properties, offering promising insights into its therapeutic applications.
Abstract
Ibogaine, a hallucinogenic indole alkaloid, has been proposed as a treatment for addiction to opioids and other drugs of abuse. The mechanism for its putative anti-addictive effects is unknown. In this study, the effects of ibogaine on local cerebral glucose utilization (LCGU) were determined in freely moving, drug-naive, or morphine-dependent adult, male, Sprague-Dawley rats using the [(14)C]2-deoxyglucose (2-DG) method. Morphine-dependent rats were treated with increasing doses of morphine (5-25 mg/kg, s.c., b.i.d.) and then maintained at 25 mg/kg (b.i.d.) for 4-7 days. For the 2-DG procedure, rats were injected with saline or ibogaine (40 mg/kg, i.p.). 2-DG was administered 1 h after administration of ibogaine. The rate of LCGU was determined by quantitative autoradiography in 46 brain regions. In drug-naive animals, ibogaine produced significant increases in LCGU in the parietal, cingulate, and occipital cortices and cerebellum compared to controls consistent with its activity as a hallucinogen and a tremorogen. Morphine-dependent rats had only minor alterations in LCGU at the time assessed in this experiment. However, in morphine-dependent animals, ibogaine produced a global decrease in LCGU that was greatest in brain regions such as the lateral and medial preoptic areas, nucleus of the diagonal band, nucleus accumbens shell, inferior colliculus, locus coeruleus, and flocculus compared to morphine-dependent animals treated with saline. These findings indicate that ibogaine produces distinctly different effects on LCGU in drug-naive and morphine-dependent rats. This suggests that different mechanisms may underlie ibogaine's hallucinogenic and anti-addictive effects.